ALB and non-small cell lung carcinoma: A novel inflammation-related marker, advanced lung cancer inflammation index (ALI), calculated from albumin, NLR and BMI (BMI × ALB/NLR), has been identified for the first time as a valid prognostic indicator in metastatic non-small cell lung cancer (NSCLC) [10].